After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?
Dear Editor, the number of cases of cancer patients diagnosed as having immune checkpoint inhibitor-mediated polymyalgia rheumatica has been steadily rising in published reports. However, the lack of a validated scale or algorithm is still a relevant methodological limit in diagnosing this nosologi...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
PAGEPress Publications
2025-03-01
|
| Schriftenreihe: | Reumatismo |
| Schlagworte: | |
| Online-Zugang: | https://www.reumatismo.org/reuma/article/view/1823 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|